Key Finding
Combined Banxia-Baizhu-Tianma Decoction and acupuncture shows preliminary evidence of superior outcomes compared to monotherapy for cerebral ischemic stroke, improving cerebral perfusion, motor function, and reducing disability rates through synergistic targeting of overlapping pathophysiological pathways.
Researchers reviewed the evidence for combining a traditional Chinese herbal formula called Banxia-Baizhu-Tianma Decoction (BBTD) with acupuncture to treat cerebral ischemic stroke, the most common type of stroke caused by blocked blood vessels in the brain. Stroke is a leading cause of death and disability worldwide, and while Western medicine can be effective immediately after a stroke occurs, it has limitations in preventing long-term neurological problems and improving recovery.
This narrative review examined how BBTD and acupuncture work individually and together. BBTD is a classical Chinese herbal formula designed to reduce phlegm, calm internal wind, and support spleen function. Studies show it protects brain cells, reduces inflammation and oxidative stress, and protects blood vessels through multiple biological pathways. Acupuncture has been recognized by the World Health Organization and works by reducing toxic levels of brain chemicals like glutamate, preventing calcium overload in cells, decreasing inflammation, and promoting the growth of new blood vessels and brain cells.
Preliminary clinical studies suggest that using BBTD and acupuncture together may work better than either treatment alone. Patients receiving combination therapy showed improvements in blood flow to the brain, reduced inflammatory markers and cholesterol levels, better motor function and ability to perform daily activities, and lower disability rates. The researchers believe these two treatments work synergistically by targeting overlapping stroke-related problems in the body. However, they emphasize the need for larger, higher-quality clinical trials to confirm these benefits. If considering acupuncture for stroke recovery, consult with a licensed acupuncturist experienced in neurological conditions.
This narrative review synthesizes current evidence on Banxia-Baizhu-Tianma Decoction (BBTD) combined with acupuncture for cerebral ischemic stroke management. The authors examine pathophysiological mechanisms and therapeutic effects of both modalities. BBTD demonstrates neuroprotective, anti-inflammatory, antioxidant, and vascular-protective properties through multi-targeted regulation, with synergistic effects among constituent herbs. Acupuncture mechanisms include inhibiting glutamate excitotoxicity, calcium overload, and inflammatory cascades while promoting angiogenesis, neurogenesis, and synaptic plasticity via neurotransmitter, cytokine, growth factor, and signaling pathway modulation. Preliminary clinical evidence suggests combination therapy may surpass monotherapy in improving cerebral perfusion, reducing inflammatory markers and lipid levels, enhancing motor function and ADLs, and decreasing disability rates. As a narrative review without specific sample sizes or effect sizes reported, the authors conclude that BBTD and acupuncture likely exert synergistic effects through overlapping pathophysiological pathways, while emphasizing the necessity for large-scale, rigorous RCTs and mechanistic studies to validate efficacy and support clinical implementation.
Browse our directory of verified licensed practitioners near you.
Find a practitioner โ๐ Traditional Chinese Medicine interventions, including herbal formulations and acupuncture, effectively enhance thyroid function, decrease autoantibody levels, and improve quality of life in Hashimoto's thyroiditis patients through immunomodulation and reduction of oxidative stress.
๐ Metabolomics reveals that acupuncture and herbal formulas consistently modulate amino acid, lipid, and energy metabolism pathways across multiple neurological disorders, providing quantitative evidence for TCM's multi-target therapeutic mechanisms.
๐ Traditional Chinese medicine therapies including acupuncture and moxibustion demonstrate significant anti-diabetic effects in Type 1 diabetes through improving insulin resistance, promoting insulin secretion, and significantly improving patient survival rates when used as adjuvant treatment.